Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Add To Watchlist

Bullboard (TSX:GUD)

View:

Post by wofatson Sep 23, 2023 1:14pm

Shorts

A large increase in the last 30 days . $GUD.TO KNIGHT THERAPEUTICS INC. 3,571,557 1,138,889 14 Sep 2023 $GUD.TO KNIGHT ...more

235

Discussion

Comment by curiousjon Sep 12, 2023 4:11pm

RE:RE:RE:Interesting Stats

a major part of COGS would be related to royalties, so upfront investments for new drug intangible to replace legacy ones would be minor relative to the royalties of 15-20%+. and also remember many ...more

211

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by EbbFlow88on Sep 12, 2023 12:28pm

RE:RE:Interesting Stats

An example in 2022 annual report: On the Income Statement, it reads "Amortization of Intangible Assets" = $51.7M Under Operating Cash Flow, it reads "Depcreciation & Amortization ...more

188

Discussion

Comment by EbbFlow88on Sep 12, 2023 12:04pm

RE:RE:Interesting Stats

So you're saying that the D&A is coming from hard assets from GBT? What about the drug deals that are being depreciated over their "useful" life and that will have to be replenished ...more

172

Discussion

Comment by curiousjon Sep 12, 2023 11:54am

RE:Interesting Stats

OCF is the most important metric for GUD. D&A is almost entirely from GBT, and so very will little goodwill. you're expensing a large part of the terminal value paid for GBT, so you save taxes ...more

156

Discussion

Post by EbbFlow88on Sep 12, 2023 11:23am

Interesting Stats

I pulled some data from the past number of annual reports. The book value has been dropping each year which is obviously not a good thing. However, the shares outstanding have been decreasing more ...more

278

Discussion

Post by wofatson Sep 12, 2023 10:49am

Someone sees value

Filed 2023-09-1118:45 Tx date 2023-09-08 $GUD Knight Therapeutics Inc. Armoyan, Sime 3 - 10% Security Holder of Issuer ...more

160

Post by GoldenInvestoron Sep 08, 2023 2:57pm

More focus coming to biotech & micro biotech

Being discussed on cnbc.

137

Comment by EbbFlow88on Sep 08, 2023 11:33am

RE:RE:RE:Adjusted enterprise value = Exelon

Nice catch on this btw. Someone from Desjardins and CIBC outside of Knights buybacks have been loading up. Hard to tell if CIBC is the same person but Desjardins likely is.

124

Discussion

Post by GoldenInvestoron Sep 08, 2023 9:32am

Question regarding revenue growth compared to Paladin

Question to the board.. How is Knight executing on its revenue growth, sales growth, & other metrics. compared to its predecessor company at similar stages of growth? is it on the same ...more

207

Comment by EbbFlow88on Sep 08, 2023 8:34am

RE:RE:RE:Adjusted enterprise value = Exelon

I agree regarding going private. I don't think they will for the reasons you gave but also because I don't think they would do that to their shareholders. Just making a point of how cheap the ...more

147

Discussion

Comment by longrun86on Sep 08, 2023 1:11am

RE:RE:Adjusted enterprise value = Exelon

There is no point in Knight going private. The company will have opportunities to grow and may wish to access capital markets (debt or equity). Knight clearly needs to improve the return profile of ...more

169

Discussion

Comment by MrMugsyon Sep 07, 2023 9:44pm

RE:Adjusted enterprise value = Exelon

EbbFlow - they didn't go private at Paladin's lows - they won't do it here. This is so predictable and quite normal. You can also take the fact that PLB never issued a dividend ...more

134

Discussion

Comment by wofatson Sep 07, 2023 2:55pm

RE:RE:Adjusted enterprise value = Exelon

Is this a good price yet? 4.28 was the year low. I suppose if you were averaging down it is . The quarter is almost done . Perhaps a new position is being started by retail Maybe stock buy ...more

138

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:GUD)